Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reason
Reason
Jacob Sullum

The Promise and Limits of Trump's Psychedelic Therapy Order

The hugely popular, politically eclectic podcaster Joe Rogan, who endorsed Donald Trump in the 2024 election, says he recently sent the president information about ibogaine, a psychedelic whose boosters portray it as an astonishingly effective treatment for addiction, post-traumatic stress disorder (PTSD), and other psychological problems. "The text message came back," Rogan said on Saturday as Trump signed an executive order aimed at "accelerating medical treatments for serious mental illness." According to Rogan, Trump replied: "Sounds great. Do you want FDA approval? Let's do it."

Trump's order may or may not result in ibogaine's approval as a psychotherapeutic catalyst. But it instructs the Food and Drug Administration (FDA) to facilitate that goal by streamlining the review process for "appropriate psychedelic drugs," including ibogaine, and providing "at leasty $50 million from existing funds" to state programs investigating their potential. The FDA also is supposed to collaborate with the Department of Veterans Affairs on clinical trials.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.